Altamira Therapeutics CYTOF
OTC CYTOF
$0.07 +0.00 (+0.00%)
At close: Nov 13, 2026 · 4:00 PM EST

Altamira Therapeutics (CYTOF) Cash & Equivalents (2013 - 2025)

Updated

Altamira Therapeutics (CYTOF) recorded Cash & Equivalents of $3,755 in Q2 2025, down 94.3% from $65,455 a year earlier.

Analysis

Altamira Therapeutics (CYTOF) Cash & Equivalents (2013 - 2025) Analysis & Trends

At the end of FY2024, Altamira Therapeutics reported Cash & Equivalents of $998,624, up 36.1% from FY2023.

  • Annual Cash & Equivalents has a five-year compound annual growth rate of -6.5% (FY2019 to FY2024).
  • Across earlier years, Cash & Equivalents came in at $733,701 in FY2023, $16,641 in FY2022 (-98.5%), $1.08 million in FY2021 (-91.3%) and $12.45 million in FY2020 (+790.1%).
  • The Q2 2025 figure is the lowest quarterly Cash & Equivalents in data going back to Q4 2016.
  • Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 790.1% in Q4 2020, against a decline of 98.4% in Q4 2022 at the low end.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 3,755.00
Dec 31, 2024 998,624.00
Jun 30, 2024 65,455.00
Dec 31, 2023 732,082.35
Jun 30, 2023 55,129.34
Jan 1, 2023 16,641.00
Dec 31, 2022 16,682.02
Jun 30, 2022 390,541.60
Dec 31, 2021 1.08 Mn
Jun 30, 2021 9.19 Mn
Dec 31, 2020 12.77 Mn
Jun 30, 2020 41,994.64
Dec 31, 2019 1.43 Mn
Jun 30, 2019 5.93 Mn
Dec 31, 2018 5.48 Mn
Sep 30, 2018 5.38 Mn
Jun 30, 2018 4.43 Mn
Mar 31, 2018 13.24 Mn
Dec 31, 2017 15.30 Mn
Sep 30, 2017 19.59 Mn
API Access

Altamira Therapeutics Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CYTOF&period=max&api_key=YOUR_API_KEY